Novel therapeutic strategies for Alzheimer’s disease targeting brain cholesterol homeostasis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel therapeutic strategies for Alzheimer’s disease targeting brain cholesterol homeostasis
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NEUROSCIENCE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-08-28
DOI
10.1111/ejn.14949
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
- (2020) Tosha Williams et al. Molecular Neurodegeneration
- Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?
- (2020) Jacques Fantini et al. PROTEIN SCIENCE
- Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
- (2020) Emma M. O’Connell et al. Frontiers in Neuroscience
- Structure of amyloid β25–35 in lipid environment and cholesterol-dependent membrane pore formation
- (2019) Nabin Kandel et al. Scientific Reports
- Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment
- (2019) Raúl Loera-Valencia et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons
- (2019) Rik van der Kant et al. Cell Stem Cell
- Oxysterol research: a brief review
- (2019) William J. Griffiths et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid beta and cholesterol homeostasis in blood-brain barrier endothelial cells
- (2019) Elham Fanaee-Danesh et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Proprotein Convertase Subtilisin/Kexin Type 9, Brain Cholesterol Homeostasis and Potential Implication for Alzheimer’s Disease
- (2019) Maria Pia Adorni et al. Frontiers in Aging Neuroscience
- CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice
- (2019) Alexey M. Petrov et al. Neurotherapeutics
- Modifiable Risk Factors for Alzheimer’s Disease
- (2019) George A. Edwards III et al. Frontiers in Aging Neuroscience
- Involvement of Epigenetic Mechanisms and Non-coding RNAs in Blood-Brain Barrier and Neurovascular Unit Injury and Recovery After Stroke
- (2019) Svetlana M. Stamatovic et al. Frontiers in Neuroscience
- Mechanisms and regulation of cholesterol homeostasis
- (2019) Jie Luo et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Small molecule inducers of ABCA1 and apoE that act through indirect activation of the LXR pathway
- (2018) Jianjia Fan et al. JOURNAL OF LIPID RESEARCH
- Increased Levels of 27-Hydroxycholesterol Induced by Dietary Cholesterol in Brain Contribute to Learning and Memory Impairment in Rats
- (2018) Xiaona Zhang et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Liver X receptors in lipid signalling and membrane homeostasis
- (2018) Bo Wang et al. Nature Reviews Endocrinology
- Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
- (2018) Melanie D. Sweeney et al. Nature Reviews Neurology
- Oxidative stress, aging, and diseases
- (2018) Ilaria Liguori et al. Clinical Interventions in Aging
- The role of statins in both cognitive impairment and protection against dementia: a tale of two mechanisms
- (2018) Bob G. Schultz et al. Translational Neurodegeneration
- Brain Cholesterol Metabolism, Oxysterols, and Dementia
- (2018) Timothy M. Hughes et al. JOURNAL OF ALZHEIMERS DISEASE
- Decline in Sirtuin-1 expression and activity plays a critical role in blood-brain barrier permeability in aging
- (2018) Svetlana M. Stamatovic et al. NEUROBIOLOGY OF DISEASE
- Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis
- (2017) Kaarin J. Anstey et al. JOURNAL OF ALZHEIMERS DISEASE
- Comparative effect of statins on the risk of incident Alzheimer disease
- (2017) Liliya Sinyavskaya et al. NEUROLOGY
- Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease
- (2017) Natalia Mast et al. NEUROPHARMACOLOGY
- Molecular Mechanisms of Antisense Oligonucleotides
- (2017) Stanley T. Crooke Nucleic Acid Therapeutics
- Alzheimer’s disease prevention: from risk factors to early intervention
- (2017) Marta Crous-Bou et al. Alzheimers Research & Therapy
- Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease
- (2017) Nophar Geifman et al. Alzheimers Research & Therapy
- Potential Mechanisms Linking Cholesterol to Alzheimer's Disease-like Pathology in Rabbit Brain, Hippocampal Organotypic Slices, and Skeletal Muscle
- (2017) Othman Ghribi JOURNAL OF ALZHEIMERS DISEASE
- Statins and Cognitive Functioning in the Elderly: A Population-Based Study
- (2017) Juliín Benito-León et al. JOURNAL OF ALZHEIMERS DISEASE
- Neuronutrition and Alzheimer's Disease
- (2017) Balenahalli N. Ramesh et al. JOURNAL OF ALZHEIMERS DISEASE
- MicroRNAs in brain cholesterol metabolism and their implications for Alzheimer's disease
- (2016) Hyejin Yoon et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Apolipoprotein E as a Therapeutic Target in Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence
- (2016) Yu Yamazaki et al. CNS DRUGS
- Cholesterol, 24-Hydroxycholesterol, and 27-Hydroxycholesterol as Surrogate Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer’s Disease: A Meta-Analysis
- (2016) Hua-Long Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- Understanding the Role of miR-33 in Brain Lipid Metabolism: Implications for Alzheimer's Disease
- (2016) Florence Jaouen et al. JOURNAL OF NEUROSCIENCE
- Relationship between oxysterols and mild cognitive impairment in the elderly: a case–control study
- (2016) Quanri Liu et al. Lipids in Health and Disease
- Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins
- (2016) Anat Boehm-Cagan et al. PLoS One
- LXR Regulation of Brain Cholesterol: From Development to Disease
- (2016) Rebecca Courtney et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Common molecular mechanism of amyloid pore formation by Alzheimer’s β-amyloid peptide and α-synuclein
- (2016) Coralie Di Scala et al. Scientific Reports
- Atorvastatin prevents Aβ oligomer-induced neurotoxicity in cultured rat hippocampal neurons by inhibiting Tau cleavage
- (2015) Hai-juan Sui et al. ACTA PHARMACOLOGICA SINICA
- ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease
- (2015) Yohei Shibuya et al. Future Medicinal Chemistry
- Oxidized cholesterol as the driving force behind the development of Alzheimer’s disease
- (2015) Paola Gamba et al. Frontiers in Aging Neuroscience
- Cholesterol metabolism and homeostasis in the brain
- (2015) Juan Zhang et al. Protein & Cell
- Bexarotene Blocks Calcium-Permeable Ion Channels Formed by Neurotoxic Alzheimer’s β-Amyloid Peptides
- (2014) Jacques Fantini et al. ACS Chemical Neuroscience
- Interaction of Alzheimer’s β-Amyloid Peptides with Cholesterol: Mechanistic Insights into Amyloid Pore Formation
- (2014) Coralie Di Scala et al. BIOCHEMISTRY
- Constitutive hippocampal cholesterol loss underlies poor cognition in old rodents
- (2014) M. G. Martin et al. EMBO Molecular Medicine
- Cholesterol in brain disease: sometimes determinant and frequently implicated
- (2014) M. G. Martin et al. EMBO REPORTS
- Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System
- (2014) Amelia McFarland et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Anti-ApoE Antibody Given after Plaque Onset Decreases A Accumulation and Improves Brain Function in a Mouse Model of A Amyloidosis
- (2014) F. Liao et al. JOURNAL OF NEUROSCIENCE
- Statins and Neuroprotection: Basic Pharmacology Needed
- (2014) W. Gibson Wood et al. MOLECULAR NEUROBIOLOGY
- More than Cholesterol Transporters: Lipoprotein Receptors in CNS Function and Neurodegeneration
- (2014) Courtney Lane-Donovan et al. NEURON
- The pharmacology of statins
- (2014) Cesare R. Sirtori PHARMACOLOGICAL RESEARCH
- Dyslipidemia and the Risk of Alzheimer’s Disease
- (2013) Christiane Reitz Current Atherosclerosis Reports
- Suppression of amyloid-β production by 24S-hydroxycholesterol via inhibition of intracellular amyloid precursor protein trafficking
- (2013) Yasuomi Urano et al. FASEB JOURNAL
- APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease
- (2013) Elisabet Barbero-Camps et al. HUMAN MOLECULAR GENETICS
- Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis
- (2013) W. Gibson Wood et al. JOURNAL OF NEUROCHEMISTRY
- The Major Brain Cholesterol Metabolite 24(S)-Hydroxycholesterol Is a Potent Allosteric Modulator of N-Methyl-D-Aspartate Receptors
- (2013) S. M. Paul et al. JOURNAL OF NEUROSCIENCE
- Gadd153 and NF-κB Crosstalk Regulates 27-Hydroxycholesterol-Induced Increase in BACE1 and β-Amyloid Production in Human Neuroblastoma SH-SY5Y Cells
- (2013) Gurdeep Marwarha et al. PLoS One
- Neuropathological Alterations in Alzheimer Disease
- (2013) A. Serrano-Pozo et al. Cold Spring Harbor Perspectives in Medicine
- Cholesterol homeostasis: a key to prevent or slow down neurodegeneration
- (2013) Laura Anchisi et al. Frontiers in Physiology
- 24S-hydroxycholesterol in plasma: A marker of cholesterol turnover in neurodegenerative diseases
- (2012) Valerio Leoni et al. BIOCHIMIE
- Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases
- (2012) J. E. Vance Disease Models & Mechanisms
- Blood-brain barrier dysfunction-induced inflammatory signaling in brain pathology and epileptogenesis
- (2012) Soo Young Kim et al. EPILEPSIA
- Cholesterol and Alzheimer's disease: A still poorly understood correlation
- (2012) Roberta Ricciarelli et al. IUBMB LIFE
- Cholesterol Level and Statin Use in Alzheimer Disease
- (2011) Nina E. Shepardson ARCHIVES OF NEUROLOGY
- Neuronal-Astrocyte Metabolic Interactions: Understanding the Transition Into Abnormal Astrocytoma Metabolism
- (2011) Dennis A. Turner et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Critical Role of Astroglial Apolipoprotein E and Liver X Receptor- Expression for Microglial A Phagocytosis
- (2011) D. Terwel et al. JOURNAL OF NEUROSCIENCE
- The projected effect of risk factor reduction on Alzheimer's disease prevalence
- (2011) Deborah E Barnes et al. LANCET NEUROLOGY
- Linking lipids to Alzheimer's disease: cholesterol and beyond
- (2011) Gilbert Di Paolo et al. NATURE REVIEWS NEUROSCIENCE
- Cholesterol metabolism in neurons and astrocytes
- (2011) Frank W. Pfrieger et al. PROGRESS IN LIPID RESEARCH
- Potential of ezetimibe in memory deficits associated with dementia of alzheimer′s type in mice
- (2010) Nirmal Singh et al. INDIAN JOURNAL OF PHARMACOLOGY
- Apolipoprotein E: From lipid transport to neurobiology
- (2010) Paul S. Hauser et al. PROGRESS IN LIPID RESEARCH
- The oxysterol 27-hydroxycholesterol increases β-amyloid and oxidative stress in retinal pigment epithelial cells
- (2010) Bhanu Dasari et al. BMC Ophthalmology
- Late onset Alzheimer’s disease in older people
- (2010) Ahmet Turan Isik Clinical Interventions in Aging
- Cholesterol as a Risk Factor for Dementia and Cognitive Decline: A Systematic Review of Prospective Studies With Meta-Analysis
- (2009) Kaarin J. Anstey et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Central nervous system: cholesterol turnover, brain development and neurodegeneration
- (2009) John M. Dietschy BIOLOGICAL CHEMISTRY
- Altered expression of claudin family proteins in Alzheimer's disease and vascular dementia brains
- (2009) Mihaela O. Romanitan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Oxysterols and neurodegenerative diseases
- (2009) Ingemar Björkhem et al. MOLECULAR ASPECTS OF MEDICINE
- Statin-Associated Adverse Cognitive Effects: Survey Results from 171 Patients
- (2009) Marcella A Evans et al. PHARMACOTHERAPY
- Evidence for Altered LRP/RAGE Expression in Alzheimer Lesion Pathogenesis
- (2008) Brian Jeynes et al. Current Alzheimer Research
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now